NAFDAC Seeks Therapeutic Medicines, Vaccines Regulation

The Director-General,  National Agency for Food and Drug Administration and Control (NAFDAC), Prof.  Moji Adeyeye, has sought  for a regulatory system for effective quality therapeutic medicines and vaccines in low and medium income countries.
He made the appeal in a statement signed by the agency’s  resident media consultant, Mr Olusayo Akintola, on Wednesday in Abuja.
The D-G made the assertion while speaking at the hybrid University of California San Francisco UCSF)-Stanford Centre of Excellence in Regulatory Science and Innovation, (UCSF-Stanford CERSI) summit in the United States.
Adeyeye spoke at the summit as the only panelist selected from Africa on the theme: “Building a Global Vision for Product and Drug Development: Challenges and Opportunities”.
Adeyeye said only  a strong regulatory system would guarantee and accelerate the development, approval, and access of safe and effective quality therapeutic medicines and vaccines in low, medium income countries of the world.
She admonished nations on the premise of strengthening regulatory system in compliance with the World Health Assembly Resolution 67.20 of 2014, to build the capacity of member states with the ultimate goal to have access to quality medicines to different low, medium income countries.
According to her, the World Health Organisation (WHO) supports member states in reaching and sustaining effective regulatory oversight of medical products through the regulatory systems strengthening RSS programme.
She explained to the global audience how NAFDAC under her leadership, used the WHO Global Benchmarking Tools to achieve the Maturity Level 3 WHO Certification Status in March 2022 and its significance to Nigeria.